{"disease":{"id":"breast-cancer-invasive","name":"breast cancer invasive"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07283718","title":"The Association Between Axillary Lymph Node Metastasis Patterns and Breast Cancer Prognosis","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2467,"lead_sponsor_name":"Wenjin Yin","has_results":false},{"nct_id":"NCT04266249","title":"CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2175,"lead_sponsor_name":"ECOG-ACRIN Cancer Research Group","has_results":false},{"nct_id":"NCT04314401","title":"National Cancer Institute \"Cancer Moonshot Biobank\"","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1600,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04622319","title":"A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1600,"lead_sponsor_name":"Daiichi Sankyo","has_results":false},{"nct_id":"NCT03669705","title":"No Axillary Surgery for Early Breast Cancer.","phase":"","overall_status":"COMPLETED","enrollment_count":1584,"lead_sponsor_name":"Lund University","has_results":false},{"nct_id":"NCT06982313","title":"Long-term Follow-up of the TAM-01 Study and Pooled Analysis of Low-dose Tamoxifen Studies in Non-invasive or Microinvasive Breast Neoplasms","phase":"","overall_status":"COMPLETED","enrollment_count":1545,"lead_sponsor_name":"Ente Ospedaliero Ospedali Galliera","has_results":false},{"nct_id":"NCT05019989","title":"Trial of Diet, Physical Activity and Breast Cancer Recurrences: the DIANA-5 Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":1542,"lead_sponsor_name":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","has_results":false},{"nct_id":"NCT01953588","title":"Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1473,"lead_sponsor_name":"Alliance for Clinical Trials in Oncology","has_results":false},{"nct_id":"NCT06716073","title":"Long-Term Outcomes of Endoscopic-assisted vs Conventional Breast-conserving Surgery in Breast Cancer Patients After Neoadjuvant Therapy: a Randomized, Multicenter, Open Label, Non-inferiority Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":1380,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT05786664","title":"Breast Cancer Survivorship Biorepository","phase":"","overall_status":"RECRUITING","enrollment_count":1300,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT06401304","title":"Oncologic, Cosmetic and Patient Reported Outcomes in Value-Based Breast Surgery (OnCoPRO Value)","phase":"","overall_status":"RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Uppsala University","has_results":false},{"nct_id":"NCT04379570","title":"Additional Support Program Via Text Messaging and Telephone-Based Counseling for Breast Cancer Patients Receiving Hormonal Therapy","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1167,"lead_sponsor_name":"Alliance for Clinical Trials in Oncology","has_results":false},{"nct_id":"NCT01334021","title":"Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1100,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT04790305","title":"Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":1072,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT04457596","title":"T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1056,"lead_sponsor_name":"Alliance for Clinical Trials in Oncology","has_results":false},{"nct_id":"NCT04021069","title":"Using Clinicopathomic Markers to Predict Neoadjuvant Chemotherapy Response in Breast Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":800,"lead_sponsor_name":"Sunnybrook Health Sciences Centre","has_results":false},{"nct_id":"NCT07505797","title":"ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"iSono Health, Inc.","has_results":false},{"nct_id":"NCT02682693","title":"Denosumab as an add-on Neoadjuvant Treatment (GeparX)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":780,"lead_sponsor_name":"GBG Forschungs GmbH","has_results":false},{"nct_id":"NCT03201861","title":"Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":762,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT06781281","title":"NabPE With or Without Serplulimab for Early-stage HR+/HER2- Breast Cancer.","phase":"","overall_status":"RECRUITING","enrollment_count":709,"lead_sponsor_name":"Henan Cancer Hospital","has_results":false},{"nct_id":"NCT05463276","title":"The Characteristics and Risk Factors of Breast Cancer Patients Trend Distinctive Regional Differences: a Cross-sectional Study","phase":"","overall_status":"COMPLETED","enrollment_count":690,"lead_sponsor_name":"Sindh Institute of Urology and Transplantation","has_results":false},{"nct_id":"NCT04245176","title":"Genetic Testing for All Breast Cancer Patients (GET FACTS)","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":400,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT04569747","title":"A Single Arm Phase II Study of ADjuvant Endocrine Therapy, Pertuzumab, and Trastuzumab for Patients With Anatomic Stage I Hormone Receptor-positive, HER2-positive Breast Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":393,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT03737695","title":"Clinical Information and Biospecimen Collection From Patients With Recurrent or Stage IV Breast Cancer","phase":"","overall_status":"SUSPENDED","enrollment_count":300,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT05300412","title":"The Role of Interleukin-7 Serum Level as Biological Marker in Breast Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":275,"lead_sponsor_name":"University Clinical Centre of Kosova","has_results":false},{"nct_id":"NCT04001829","title":"Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":249,"lead_sponsor_name":"ECOG-ACRIN Cancer Research Group","has_results":true},{"nct_id":"NCT05710328","title":"Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":235,"lead_sponsor_name":"ECOG-ACRIN Cancer Research Group","has_results":false},{"nct_id":"NCT07527468","title":"HISMAR: Intraoperative Margin Assessment Using the Histolog® Scanner to Reduce Reoperation in Breast-Conserving Surgery","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":228,"lead_sponsor_name":"Hôpital du Valais","has_results":false},{"nct_id":"NCT03664895","title":"Density Lowering Effect of \"OFS Add on to TMX\"(DELFINO Trial)","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":224,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT04398914","title":"Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":216,"lead_sponsor_name":"Shanghai Jiao Tong University School of Medicine","has_results":false},{"nct_id":"NCT04999917","title":"Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":206,"lead_sponsor_name":"XEOS Medical","has_results":false},{"nct_id":"NCT06583655","title":"Precision Regional Node Irradiation for Sentinel Node-positive Breast Cancer","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":205,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT06763328","title":"Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT04074720","title":"Prospective Breast Cancer Biospecimen Collection","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Thomas Jefferson University","has_results":false},{"nct_id":"NCT06678204","title":"Evaluating Illustrated Vs. Traditional Pamphlets for Enhancing Self-Care in Radiation Therapy Patients","phase":"NA","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Chung Shan Medical University","has_results":false},{"nct_id":"NCT05351424","title":"AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc","phase":"NA","overall_status":"RECRUITING","enrollment_count":194,"lead_sponsor_name":"Columbia University","has_results":false},{"nct_id":"NCT04294225","title":"Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":161,"lead_sponsor_name":"Mayo Clinic","has_results":true},{"nct_id":"NCT06144944","title":"Neoadjuvant Pyrotinib in HR-positive and HER2-low High-risk Early Breast Cancer","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":160,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT03971409","title":"Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":145,"lead_sponsor_name":"Laura Huppert, MD, BA","has_results":false},{"nct_id":"NCT02515110","title":"Hypofractionated Regional Nodal Irradiation Clinical Trial for Women With Breast Cancer","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":137,"lead_sponsor_name":"Virginia Commonwealth University","has_results":false},{"nct_id":"NCT06823414","title":"Endoscopy/Robotic Assisted Nipple Skin Sparing Mastectomy","phase":"","overall_status":"RECRUITING","enrollment_count":126,"lead_sponsor_name":"Alejandra García-Novoa","has_results":false},{"nct_id":"NCT06234488","title":"Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":125,"lead_sponsor_name":"Medical College of Wisconsin","has_results":false},{"nct_id":"NCT07044791","title":"Metabolic Parameters and Quality of Life in Women on Neo-/Adjuvant Therapy for Breast Cancer","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Federico II University","has_results":false},{"nct_id":"NCT06977698","title":"Intra-operative Detection of Positive Margins in Breast Surgery","phase":"","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"University of Nottingham","has_results":false},{"nct_id":"NCT07026292","title":"Supermicrosurgical Lymphaticovenous Anastomosis for Prevention of Upper Limb Lymphedema","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Tianjin Medical University Cancer Institute and Hospital","has_results":false},{"nct_id":"NCT05023967","title":"Metformin and Nightly Fasting in Women With Early Breast Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":120,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT05301881","title":"COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":118,"lead_sponsor_name":"The Netherlands Cancer Institute","has_results":false},{"nct_id":"NCT03344965","title":"Olaparib In Metastatic Breast Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":114,"lead_sponsor_name":"Beth Israel Deaconess Medical Center","has_results":false},{"nct_id":"NCT05545150","title":"Volumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast Ductal Carcinoma In Situ, The VIVID Study","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":113,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT01052740","title":"X-Ray Mammography Standard of Care Protocol","phase":"","overall_status":"COMPLETED","enrollment_count":108,"lead_sponsor_name":"National Institutes of Health Clinical Center (CC)","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}